Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sun Pharma, Alembic and 1 other recall products

Medtronic voluntary recalls MiniMed 600 series or 700 series insulin pumps due to potential risks of shortened pump battery life

Ruchika Sharma7 Oct 2024 2:00 PM IST

Galway: Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed 600 series or 700 series...

Natco Pharma partner Mylan settles patent litigation with Novo Nordisk over generic Ozempic in US

Ruchika Sharma7 Oct 2024 12:30 PM IST

Hyderabad: NATCO Pharma Limited has announced that its partner Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement of the U.S....

Granules India arm gets 1 USFDA observation for Hyderabad facility

Lupin gets 5 USFDA observations for Pune biotech facility

Ruchika Sharma7 Oct 2024 11:30 AM IST

Mumbai: Lupin has announced that the US Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection with five observations at...

Record sales of Rs 200 crore achieved by Jan Aushadhi Kendras in September

Ruchika Sharma6 Oct 2024 2:15 PM IST

New Delhi: Record sales of Rs 200 crore were achieved by Jan Aushadhi Kendras under Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) in...

Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag International

JnJ seeks USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma patients for whom transplant is not planned

Ruchika Sharma6 Oct 2024 10:30 AM IST

Raritan: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...

Shilpa Medicare arm partners with Orion Corporation for Recombinant Human Albumin for European Market

Shilpa Pharma Lifesciences receives CEP from EDQM for API, Desmopressin

Ruchika Sharma6 Oct 2024 10:00 AM IST

Karnataka: Shilpa Medicare Limited's 100% subsidiary, Shilpa Pharma Lifesciences Limited has received certificate of suitability (CEP) from EDQM...

CDSCO Panel Clears AstraZenecas Datopotamab for Breast Cancer, Seeks Phase IV Trial

Astrazeneca Calquence granted priority review by USFDA for previously untreated mantle cell lymphoma

Ruchika Sharma5 Oct 2024 2:30 PM IST

Cambridge: AstraZeneca's supplemental New Drug Application (sNDA) for Calquence (acalabrutinib) has been accepted and granted Priority Review in...

Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatment

USFDA nod to Perioperative treatment of Neoadjuvant Opdivo, Chemotherapy followed by Surgery, Adjuvant Single Agent Opdivo for Resectable Non Small Cell Lung Cancer

Ruchika Sharma5 Oct 2024 1:25 PM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) for the...

Lupin arm buys nine brands of Medical Nutritional Institute in South Africa

Ruchika Sharma5 Oct 2024 12:30 PM IST

The acquired brands include AntaGolin, RyChol, NeuroVance, SkinVance, FlamLeve, Rheumalin, SleepVance, ImmunoVance, and OviVance.

Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance Officer

Biocon Biologics refinances USD 1.1 billion long term debt through USD Bonds new syndicated facility

Ruchika Sharma5 Oct 2024 11:30 AM IST

Bengaluru: Biocon Biologics Limited, a subsidiary of Biocon Limited, has announced the successful pricing of Biocon Biologics' debut USD 800 million...

Pune Pharmacist Loses Rs 95 Lakh in Medical Store Deal

Delhi HC refuses bail to man accused of producing, supplying spurious anti-cancer medicines

Ruchika Sharma4 Oct 2024 4:56 PM IST

New Delhi: The Delhi High Court has denied bail to a man accused of being the kingpin behind the production and distribution of spurious anti-cancer...

Himachal to develop medical device park independently

CDSCO becomes Affiliate Member of International Medical Device Regulators Forum

Ruchika Sharma4 Oct 2024 2:55 PM IST

New Delhi: Central Drugs Standard Control Organization (CDSCO) under Ministry of Health & Family Welfare has become Affiliate Member of the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok